Prostate MRI based on PI-RADS version 2: how we review and report.

Steiger, Philipp; Thöny, Harriet C. (2016). Prostate MRI based on PI-RADS version 2: how we review and report. Cancer imaging : the official publication of the International Cancer Imaging Society, 16(9), p. 9. BioMed Central 10.1186/s40644-016-0068-2

[img]
Preview
Text
art_10.1186_s40644-016-0068-2.pdf - Published Version
Available under License Creative Commons: Attribution (CC-BY).

Download (3MB) | Preview

Prostate imaging and interpretation is based on prostate imaging reporting and data system version 2 (PI-RADS™ v2) providing clinical guidelines for multiparametric magnetic resonance imaging (mpMRI) of the prostate. PI-RADS™ v2 aims to promote global standardisation, to diminish variation in the acquisition, interpretation and reporting of prostate mpMRI examinations and to improve detection, localisation, and risk stratification in patients with suspected cancer in treatment naïve prostate glands. It does not address detection of recurrence, progression during active surveillance and evaluation of other parts of the body.PI-RADS™ v2 improves and standardises communication between radiologists and urologists to detect or exclude the presence of significant prostate cancer with a high likelihood. Findings on mpMRI are assessed on a 5-point category scale based on the probability that a combination of findings on T2-weighted (T2w) sequences, diffusion-weighted MRI (DWI) and dynamic contrast-enhanced MRI (DCE-MRI) correlates with the presence of a clinically significant prostate cancer at a particular location. PI-RADS assessment categories range from 1 to 5 with 5 being most likely to represent clinically significant prostate cancer. The dominant sequence to detect prostate cancer in the peripheral zone is DWI, whereas for tumour detection in the transition zone T2w is the most important sequence. DCE-MRI has been attributed a minor role and only qualitative assessment with presence or absence of focal enhancement is suggested. Up to four suspicious lesions of category 3, 4 and 5 are assigned on a sector map and the index lesion should be identified.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Radiology, Neuroradiology and Nuclear Medicine (DRNN) > Institute of Diagnostic, Interventional and Paediatric Radiology

UniBE Contributor:

Steiger, Philipp and Thöny, Harriet C.

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1470-7330

Publisher:

BioMed Central

Language:

English

Submitter:

Philipp Steiger

Date Deposited:

24 May 2017 11:45

Last Modified:

28 May 2017 02:19

Publisher DOI:

10.1186/s40644-016-0068-2

PubMed ID:

27067275

Uncontrolled Keywords:

Multiparametric magnetic resonance imaging (mpMRI); Prostate Imaging Reporting and Data System version 2 (PI-RADS™ v2); Prostate cancer

BORIS DOI:

10.7892/boris.99569

URI:

https://boris.unibe.ch/id/eprint/99569

Actions (login required)

Edit item Edit item
Provide Feedback